Nitric oxide delivering devices to prevent saphenous vein graft failure?

Cardiology

Volumn 118, Issue 2, 2011, Pages 104-106

  Suvorava, Tatsiana ^a   Kojda, Georg ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; NITRIC OXIDE; RAPAMYCIN;

CORONARY ARTERY BYPASS GRAFT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELUTING STENT; EDITORIAL; ENZYME INHIBITION; GEL; GRAFT FAILURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SAPHENOUS VEIN GRAFT FAILURE; VEIN OCCLUSION;

ANIMALS; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FEMALE; GRAFT OCCLUSION, VASCULAR; NITRIC OXIDE; SAPHENOUS VEIN;

EID: 79955564679     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000327095     Document Type: Editorial

References (21)

1. Pfisterer ME, Zellweger MJ, Gersh BJ: Management of stable coronary artery disease. Lancet 2010;375:763-772.
2. Parang P, Arora R: Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 2009;25:e57-e62.
3. Alexander JH, Hafley G, Harrington RA, et al: Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 2005;294:2446-2454. (Pubitemid 41627922)
4. Conti VR, Hunter GC: Gene therapy and vein graft patency in coronary artery bypass graft surgery. JAMA 2005;294:2495-2497. (Pubitemid 41627929)
5. Lau GT, Lowe HC, Kritharides L: Cardiac saphenous vein bypass graft disease. Semin Vasc Med 2004;4:153-159. (Pubitemid 39433666)
6. Jorapur V, Cano-Gomez A, Conde CA: Should saphenous vein grafts be the conduits of last resort for coronary artery bypass surgery? Cardiol Rev 2009;17:235-242.
7. Hozumi T, Yoshikawa J, Yoshida K, et al: Use of intravascular ultrasound for in vivo assessment of changes in intimal thickness of angiographically normal saphenous vein grafts one year after aortocoronary bypass surgery. Heart 1996;76:317-320. (Pubitemid 26355980)
8. Lüscher TF, Diedrich D, Siebenmann R, Lehmann K, Stülz P: Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 1988;319:462-467.
9. Gewaltig MT, Kojda G: Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 2002;55:250-260. (Pubitemid 34775275)
10. Hacker A, Müller S, Meyer W, Kojda G: The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis. Br J Pharmacol 2001;132:1707-1714. (Pubitemid 32397962)
11. Muller S, Konig I, Meyer W, Kojda G: Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate. J Am Coll Cardiol 2004;44:624-631. (Pubitemid 39078190)
12. Kojda G, Hambrecht R: Molecular mechanisms of vascular adaptations to exercise: physical activity as an effective antioxidant therapy? Cardiovasc Res 2005;67:187-197.
13. Kojda G, Cheng YC, Burchfield J, Harrison DG: Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one eNOS gene. Circulation 2001;103:2839-2844. (Pubitemid 32550074)
14. Dao T, Floeren M, Kumpf S, et al: Catalase activity prevents exercise-induced upregulation of vasoprotective proteins in venous tissue. J Cell Mol Med 2010, E-pub ahead of print. DOI: 10.1111/j.1582-4934.2010.01227.x.
15. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG: Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 2000;105:1631-1639.
16. Suvorava T, Lauer N, Kojda G: Physical inactivity causes endothelial dysfunction in healthy young mice. J Am Coll Cardiol 2004;44:1320-1327. (Pubitemid 39208892)
17. Hambrecht R, Wolf A, Gielen S, et al: Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000;342:454-460. (Pubitemid 30100232)
18. Kushwaha M, Anderson JM, Bosworth CA, et al: A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices. Biomaterials 2010;31:1502-1508.
19. Abbasi K, Shalileh K, Anvari MS, Rabbani S, Mahdanian A, Ahmadi SH, Moshtaghi N, Movahedi N, Karimi A: Perivascular nitric oxide delivery to saphenous vein grafts prevents graft stenosis after coronary artery by-pass grafting: a novel sheep model. Cardiology 2011;118:8-15.
20. Keefer LK, Nims RW, Davies KM, Wink DA: 'NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 1996;268:281-293. (Pubitemid 26286370)
21. Sousa JE, Serruys PW, Costa MA: New frontiers in cardiology: drug-eluting stents. Part I. Circulation 2003;107:2274-2279. (Pubitemid 36547225)